0 results for 'Boehringer Ingelheim'
Lawsuits Surge in Philadelphia's Zantac Mass Tort Program as More Plaintiffs Turn to State Courts
The Zantac program is now the largest of four mass torts to have been established in Philadelphia's Complex Litigation Center in 2022.
Supreme Court to Resolve Circuit Split Regarding Attorney-Client Privilege
In its current term, the Supreme Court is set to decide whether a "dual-purpose" communication is protected by the attorney-client privilege where obtaining or providing legal advice was "one of the significant purposes" of the communication.
New Director Reviews: The Latest IPR Guidance From the Patent Office
The new Patent Office director has invoked her director review power to reconsider the Board's decisions 10 times, issuing six decisions to date spanning a broad range of issues, says Armond Wilson's Josepher Li and Michelle Armond.
King & Spalding Bolsters Litigation in New York, Aiming for the Stratosphere
Recent hires such as Randy Mastro and Mark Kirsch in New York are part of a larger plan to elevate the firm's presence in New York, "the most important and competitive legal market in the world," according to it chairman.
Atlanta's King & Spalding Doubles Down on Litigation, Aiming for the Stratosphere
Recent hires such as Randy Mastro and Mark Kirsch in New York are part of a larger plan to elevate the firm's presence in New York, "the most important and competitive legal market in the world," according to it chairman.
Law Journal Press | Digital Book
Wrongful Use of Civil Proceedings and Related Torts in Pennsylvania, Second Edition
Authors: George Bochetto, David P. Heim, John A. O’Connell, Robert S. Tintner
View this Book
View more book results for the query "Boehringer Ingelheim"
King & Spalding Doubles Down on Litigation, Aiming for the Stratosphere
Recent hires such as Randy Mastro and Mark Kirsch in New York are part of a larger plan to elevate the firm's presence in New York, "the most important and competitive legal market in the world," according to it chairman.
More Than 200 Superior Court Suits Link Zantac to Cancer
Dozens of plaintiffs are named in each case, which were filed from Aug. 23 to 26.
More Than 200 Products Liability Suits Linking Zantac to Cancer Land in Del. Superior Court
Dozens of plaintiffs are named in each case, which were filed from Aug. 23 to 26.
Sanofi, GSK and Pfizer Lose Billions in Value on Zantac Woes
Zantac was a once-popular antacid that has drawn a flurry of U.S. personal-injury lawsuits alleging it causes cancer.
The Benefits, Consequences and Pitfalls of Terminal Disclaimers
A terminal disclaimer—a seemingly simple document that shortens a patent's life by declaring that it expires upon the expiration of another commonly owned patent—is replete with technical and substantive traps for the unwary and far-reaching consequences during both prosecution and enforcement of U.S. patents.TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Vaishali Rao, Hinshaw & Culbertson Partner 1 minute read
Resources
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now